Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

PHASE3TerminatedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 3, 2020

Study Completion Date

April 10, 2020

Conditions
Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days
Interventions
DRUG

Smoflipid 20% (investigational lipid for parenteral nutrition)

"Dose: The targeted maximal dose is 3.0 g/kg/day. In patients already receiving parenteral nutrition (PN) before starting study treatment, the dose will either stay at 3.0 g/kg/day or be increased by 1.0 g/kg/day steps to a maximum of 3.0 g/kg/day.~Smoflipid 20% will be infused over 20 - 24 hours, as per hospital policy, at a weight based infusion rate.~Smoflipid 20% will be infused into a central or a peripheral vein."

DRUG

Intralipid® 20%

"Dose: The targeted maximal dose is 3.0 g/kg/day. In patients already receiving parenteral nutrition (PN) before starting study treatment, the dose will either stay at 3.0 g/kg/day or be increased by 1.0 g/kg/day steps to a maximum of 3.0 g/kg/day.~Intralipid® 20% will be infused over 20 - 24 hours, as per hospital policy, at a weight based infusion rate.~Intralipid® 20% will be infused into a central or peripheral vein."

Trial Locations (13)

10029

Mount Sinai Hospital, New York

11040

Steven & Alexandra Cohen Children's Medical Center of NY, New York

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

37345

Vanderbilt Children's Hospital, Nashville

73104

The Children's Hospital at OU Medical Center, Oklahoma City

77030

Texas Children's Hospital, Houston

92103

UC San Diego Medical Center, San Diego

92123

Rady Children's Hospital San Diego, San Diego

94304

Lucile Packard Children's Hospital, Palo Alto

06510

Yale - New Haven Children's Hospital, New Haven

60611-2991

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

68198-1205

University of Nebraska Medical Center, Omaha

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Fresenius Kabi

INDUSTRY